Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation

Endocrinology

Volumn 144, Issue 7, 2003, Pages 3251-3261

  Wu, Zheng ^a   Maric, Christine ^b   Roesch, Darren M ^b   Zheng, Wei ^b   Verbalis, Joseph G ^b   Sandberg, Kathryn ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; RNA BINDING PROTEIN;

ADRENAL GLAND; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN METABOLISM; FEMALE; GENETIC REGULATION; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; NONHUMAN; OSMOTIC PUMP; POLYSOME; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA TRANSLATION; TRANSLATION INITIATION; ZONA GLOMERULOSA;

ADRENAL CORTEX; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CELL NUCLEUS; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE EXPRESSION; OVARIECTOMY; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RECEPTORS, ESTROGEN; RNA, MESSENGER; VASOCONSTRICTOR AGENTS;

EID: 0037634546     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0015     Document Type: Article

References (60)

1. Castelli WP 1988 Cardiovascular disease in women. Am J Obstet Gynecol 158:1553-1560, 1566-1567
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
3. Sandberg K 2002 HRT and SERMs: the good, the bad . . . and the lovely? Trends Endocrinol Metab 13:317
4. Nasr A, Breckwoldt M 1998 Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 12:43-59
5. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA 1997 Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95:39-45
6. Harvey PJ, Wing LM, Savage J, Molloy D 1999 The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women. J Hypertens 17:405-411
7. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators. N Engl J Med 328:1069-1075
8. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 325:756-762
9. Barrett-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. JAMA 265:1861-1867
10. Gerhard M, Ganz P 1995 How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 92:5-8
11. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E 1997 Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 96:2468-2482
12. Corvol P, Jeunemaitre X, Charru A, Kotelevtsev Y, Soubrier F 1995 Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog Horm Res 50:287-308
13. Klett C, Ganten D, Hellmann W, Kaling M, Ryffel GU, Weimar-Ehl T, Hackenthal E 1992 Regulation of angiotensinogen synthesis and secretion by steroid hormones. Endocrinology 130:3660-3668
14. Brosnihan KB, Weddle D, Anthony MS, Heise C, Li P, Ferrario CM 1997 Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 15:719-726
15. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB 1999 Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33:323-328
16. 1 receptors in the dorsomedial arcuate nucleus of the female rat. Endocrinology 133:939-941
17. 1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201
18. Krishnamurthi K, Verbalis JG, Zheng W, Wu Z, Clerch LB, Sandberg K 1999 Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA. Endocrinology 140:5431-5434
19. Rosenfeld CR, Jackson GM 1984 Estrogen-induced refractoriness to the pressot effects of infused angiotensin II. Am J Obstet Gynecol 148:429-435
20. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG, Sandberg K 2000 Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 141:4629-4636
21. Rahmouni K, Barthelmebs M, Grima M, Imbs JL, Wybren De J 1999 Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats. Hypertension 33:1201-1206
22. Brownie AC 1995 The adrenal cortex in hypertension: DOCA/salt hypertension and beyond. In: Laragh JH, ed. Hypertension: pathophysiology, diagnosis, and management. Philadelphia: Lippincott Williams & Wilkins; 2127
23. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators [see comments]. N Engl J Med 341:709-717
24. Sandberg K, Ji H, Clark AJ, Shapira H, Catt K 1992 Cloning and expression of a novel rat angiotensin II receptor subtype. J Biol Chem 267:9455-9458
25. Sagliocco FA, Moore PA, Brown AJP 1996 Polysome analysis. Methods Mol Biol 53:297-311
26. Davies E, Abe S 1995 Methods for isolation and analysis of polyribosomes. Methods Cell Biol 50:209-222
27. Henderson SR, Baker C, Fink G 1977 Oestradiol-17β and pituitary responsiveness to luteinizing hormone releasing factor in the rat: a study using rectangular pulses of oestradiol-17β monitored by non-chromatographic radioimmunoassay. J. Endocrinol 73:441-453
28. Davies HG, Giorgini F, Fajardo MA, Braun RE 2000 A sequence-specific RNA binding complex expressed in murine germ cells contains MSY2 and MSY4. Dev Biol 221:87-100
29. Tena-Sempere M, Rannikko A, Kero J, Zhang FP, Huhtaniemi IT 1997 Molecular mechanisms of reappearance of luteinizing hormone receptor expression and function in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate. Endocrinology 138:3340-3348
30. Parker MG 1995 Structure and function of estrogen receptors. Vitam Horm 51:267-287
31. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB 1997 Tissue distribution of estrogen receptors α (ER-α) and β (ER-β) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 82:3509-3512
32. Curtis SH, Korach KS 2000 Steroid receptor knockout models: phenotypes and responses illustrate interactions between receptor signaling pathways in vivo. Adv Pharmacol 47:357-380
33. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? [published erratum appears in Endocr Rev 20:459]. Endocr Rev 20:358-417
34. Hagenfeldt Y, Eriksson HA 1988 The estrogen receptor in the rat kidney. Ontogeny, properties and effects of gonadectomy on its concentration. J Steroid Biochem 31:49-56
35. Hirst JJ, West NB, Brenner RM, Novy MJ 1992 Steroid hormone receptors in the adrenal glands of fetal and adult rhesus monkeys. J Clin Endocrinol Metab 75:308-314
36. Takao T, Nanamiya W, Nazarloo HP, Matsumoto R, Asaba K, Hashimoto K 2003 Exposure to the environmental estrogen bisphenol A differentially modulated estrogen receptor-α and -β immunoreactivity and mRNA in male mouse testis. Life Sci 72:1159-1169
37. Sakaguchi H, Fujimoto J, Aoki I, Tamaya T 2002 Expression of estrogen receptor α and β in myometrium of premenopausal and postmenopausal women. Steroids 68:11-19
38. Campbell CH, Bulayeva N, Brown DB, Gametchu B, Watson CS 2002 Regulation of the membrane estrogen receptor-α: role of cell density, serum, cell passage number, and estradiol. FASEB J 16:1917-1927
39. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME 1998 Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 83:224-229
40. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME 2002 Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295:505-508
41. Roesch D, Zheng W, Tian Y, Verbalis JG, Sandberg K 1999 Estrogen decreases angiotensin-induced aldosterone production and adrenal AT1 receptor expression in ovariectomized rats. J Am Soc Nephrol 10:461a
42. Llorens-Cortes C, Greenberg B, Huang H, Corvol P 1994 Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24: 538-548
43. Gasc JM, Shanmugam S, Sibony M, Corvol P 1994 Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24:531-537
44. Nishihara E, Nagayama Y, Inoue S, Hiroi H, Muramatsu M, Yamashita S, Koji T 2000 Ontogenetic changes in the expression of estrogen receptor α and β in rat pituitary gland detected by immunohistochemistry. Endocrinology 141:615-620
45. 1a angiotensin receptor gene. Circ Res 73:612-621
46. Langford K, Frenzel K, Martin BM, Bernstein KE 1992 The genomic organization of the rat AT1 angiotensin receptor. Biochem Biophys Res Commun 183:1025-1032
47. Maruyama S, Fujimoto N, Asano K, Ito A 2001 Suppression by estrogen receptor β of AP-1 mediated transactivation through estrogen receptor α. J Steroid Biochem Mol Biol 78:177-184
48. Hanson MN, Schoenberg DR 2001 Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1. J Biol Chem 276:12331-12337
49. Fagan RJ, Rozen R 1993 Translational control of ornithine-delta-aminotransferase (OAT) by estrogen. Mol Cell Endocrinol 90:171-177
50. McCarthy JE, Kollmus H 1995 Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem Sci 20:191-197
51. Burd CG, Dreyfuss G 1994 Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-621
52. Kash JC, Menon KM 1998 Identification of a hormonally regulated luteinizing hormone/human chorionic gonadotropin receptor mRNA binding protein. Increased mrna binding during receptor down-regulation. J Biol Chem 273: 10658-10664
53. Prokipcak RD, Herrick DJ, Ross J 1994 Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J Biol Chem 269:9261-9269
54. Pandey NB, Williams AS, Sun JH, Brown VD, Bond U, Marzluff WF 1994 Point mutations in the stem-loop at the 3′ end of mouse histone mRNA reduce expression by reducing the efficiency of 3′ end formation. Mol Cell Biol 14: 1709-1720
55. Nickenig G, Murphy TJ 1996 Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol 50:743-751
56. Thekkumkara TJ, Thomas WG, Motel TJ, Baker KM 1998 Functional role for the angiotensin II receptor (AT1A) 3′-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins. Biochem J 329:255-264
57. Pende A, Giacche M, Castigliola L, Contini L, Passerone G, Patrone M, Port JD, Lotti G 1999 Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA. Biochem Biophys Res Commun 266:609-614
58. Hershey JW 1991 Translational control in mammalian cells. Annu Rev Biochem 60:717-755
59. Klausner RD, Rouault TA 1993 A double life: cytosolic aconitase as a regulatory 5′LS BP. Mol Biol Cell 4:1-5
60. Gray NK, Hentze MW 1994 Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J 13:3882-3891